DeepCurrents Investment Group LLC

Q4 2019 13F Holdings Report, Stock Holdings

Signature - Title
Chris Walsh - Chief Operating Officer and Chief Compliance Officer
Location
New York, NY
Holdings as of
31 Dec 2019
Value $
$2,160,155,000
Num holdings
92
Filing time
14 Feb 2020, 12:02:11 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included MEDICINES CO, RESTORATION HARDWARE HLDGS I, DEXCOM INC, SAREPTA THERAPEUTICS INC, and TESLA INC.
Previous filing
Q3 2019 - 14 Nov 2019
Next filing
Q1 2020 - 15 May 2020
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2019 Q4 compared to 2019 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Chris Walsh Chief Operating Officer and Chief Compliance Officer New York, New York 14 Feb 2020

Other Included Managers (1):

Num Name Location File Number
1 Verition Fund Management LLC Greenwich, CT 028-13309